$640.63 $0.29 (0.0%)

04:30 PM EDT on 07/09/20

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

CAPS Rating: 4 out of 5

The Company is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions.

Current Price $640.63 Mkt Cap $65.0B
Open $648.00 P/E Ratio 30.74
Prev. Close $640.34 Div. (Yield) $0.00 (0.0%)
Daily Range $629.00 - $655.93 Volume 1,003,947
52-Wk Range $271.37 - $653.53 Avg. Daily Vol. 1,536,190

Caps

How do you think NASDAQ:REGN will perform against the market?

Add Stock to CAPS Watchlist

All Players

399 Outperform
70 Underperform
 

All-Star Players

101 Outperform
12 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:REGN Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Morass (< 20)
Submitted September 07, 2014

REGN has a pipeline of potential biotech products.

PDTBiotech (63.68)
Submitted February 25, 2012

$9.7B? Lots of obstacles, including Lucentis, Avastin, payers, etc., and the market is acting like they've already hit huge numbers. Strange self-limiting value prop on this, they had to develop it based on decreased injection frequency rather than… More

NASDAQ:REGN VS S&P 500 (SPY)

Fools bullish on NASDAQ:REGN are also bullish on:

Fools bearish on NASDAQ:REGN are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about REGN.

Recs

0
Member Avatar JaxPicks (67.29) Submitted: 4/23/2020 12:07:16 PM : Outperform Start Price: $569.78 NASDAQ:REGN Score: +1.24

Pharma co. with good growth at reasonable p/e with high GM and ROIC.

Recs

0
Member Avatar TMFAdriaCimino (55.74) Submitted: 4/16/2020 6:05:29 AM : Outperform Start Price: $525.30 NASDAQ:REGN Score: +9.38

A blockbuster drug for macular degeneration and collaborations with big pharma companies make this company one that could deliver revenue into the future.

Recs

0
Member Avatar TMFBigFrog (69.90) Submitted: 6/9/2019 3:07:03 PM : Outperform Start Price: $305.11 NASDAQ:REGN Score: +101.38

Longer run opportunity looks stronger than today's valuation.

Leaderboard

Find the members with the highest scoring picks in REGN.

Score Leader

oneisthelonelies

oneisthelonelies (< 20) Score: +4,298.04

The Score Leader is the player with the highest score across all their picks in REGN.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
oneisthelonelies < 20 8/6/2007 Outperform 5Y $14.15 +4,427.42% +129.38% +4,298.04 0 Comment
DNAdivaSTL 51.07 7/8/2008 Outperform NS $14.30 +4,379.93% +159.27% +4,220.66 0 Comment
kiranmn < 20 5/27/2009 Outperform 3Y $14.49 +4,321.19% +247.25% +4,073.94 0 Comment
Grinnell4Eva < 20 6/6/2008 Outperform 1Y $14.88 +4,205.31% +138.28% +4,067.03 0 Comment
stlb1ues 67.27 6/26/2008 Outperform 1Y $14.96 +4,182.29% +148.33% +4,033.96 0 Comment
mpearson29 76.89 11/25/2008 Outperform NS $14.74 +4,246.20% +269.00% +3,977.20 0 Comment
giffman62 < 20 6/6/2008 Outperform NS $15.22 +4,109.13% +132.09% +3,977.05 1 Comment
Pmccorm 94.88 6/5/2008 Outperform 3Y $15.28 +4,092.60% +133.38% +3,959.22 0 Comment
benes27 69.75 6/5/2008 Outperform 3M $15.28 +4,092.60% +133.43% +3,959.17 0 Comment
UncleSmitty 55.27 7/14/2008 Outperform NS $15.24 +4,103.61% +158.59% +3,945.02 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for REGN.